特殊人群肝豆状核变性诊治进展*

doi:10.3969/j.issn.1672-5069.2015.01.026

实用肝脏病杂志 ›› 2015, Vol. 18 ›› Issue (1): 89-91.doi: 10.3969/j.issn.1672-5069.2015.01.026

特殊人群肝豆状核变性诊治进展^*

曹海霞综述, 范建高审校

200092 上海市上海交通大学医学院附属新华医院消化内科

收稿日期:2014-05-07 出版日期:2015-12-17 发布日期:2015-12-17
通讯作者: 范建高,E-mail:fanjiangao@gmail.com E-mail:caohaixia204106@126.com
作者简介:曹海霞,女,32岁,博士研究生,主治医师。主要从事慢性肝病的防治研究。E-mail:caohaixia204106@126.com
基金资助:
上海交通大学医学院基金（编号：13XJ10021）; 中国肝炎防治基金会资助项目（编号：cfhpc20132061）

What is special in patients with Wilson's disease in children and pregnant women

Cao Haixia, Fan Jiangao

Department of Gastroenterology,Xinhua Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200092,China

Received:2014-05-07 Online:2015-12-17 Published:2015-12-17

摘要/Abstract

摘要： 肝豆状核变性的临床表现具有异质性,早期诊断较难,容易漏诊。尽管肝豆状核变性是一种遗传代谢性疾病,但若能早期诊断,根据患者的临床特点制定治疗方案,治疗效果较佳,长期预后较好。妊娠、儿童、急性肝衰竭等特殊人群的治疗仍是临床医生关注的热点问题。

关键词: 肝豆状核变性, 诊断, 治疗, 急性肝衰竭

Abstract: The clinical manifestations of Wilson's disease appear to be variable and it is sometimes difficult to diagnose at early stage. Although it is a genetic disorder of copper metabolism, if discovered early,effective treatments are available and the prognosis is good. The management of this disease in pregnant women, children and patient with acute liver failure,is highly concerned in clinical practice.

Key words: Wilson's disease, Diagnosis, Treatment, Acute liver failure

曹海霞, 范建高. 特殊人群肝豆状核变性诊治进展^*[J]. 实用肝脏病杂志, 2015, 18(1): 89-91.

Cao Haixia, Fan Jiangao. What is special in patients with Wilson's disease in children and pregnant women[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(1): 89-91.

参考文献

[1] Ala A,Walker AP,Ashkan K,et al. Wilson’sdisease. Lancet,2007,369（9559）:397-408.
[2] Loudianos G,Lepori MB,Mameli E,et al. Wilson's disease. Prilozi,2014,35（1）:93-98.
[3] Roberts EA,Schilsky ML. American association for study of liver diseases（AASLD）. Diagnosis and treatment of Wilson diseasean update. Hepatology,2008,47（6）:2089-2111.
[4] European association for study of the liver. EASL clinical practice guidelines:Wilson’s disease. J Hepatol,2012,56（3）:671-685.
[5] Ferenci P. Phenotype-genotype correlations in patients with Wilson’s disease.Ann N Y Acad Sci,2014,1315（1）:1-5.
[6] 中华医学会神经病学分会帕金森病及运动障碍学组,中华医学会神经病学分会神经遗传病学组. 肝豆状核变性的诊断与治疗指南. 中华神经科杂志,2008,41（8）:566-569.
[7] Medici V,Rossaro L,Sturnioolo GC. Wilson disease-a practical approach to diagnosis,treatment and follow-up. Dig Liver Dis, 2007,39（7）:601-609.
[8] Tauber J,Steinert RF. Pseudo-Kayser-Fleischer ring of the cornea associatedwith non-Wilsonian liver disease. A case report and literature review.Cornea,1993,12（1）:74-77.
[9] Dunn LL,Annable WL,Kliegman RM. Pigmented corneal rings in neonateswith liver disease. J Pediatr,1987,110（5）:771-776.
[10] Medici V,Trevisan CP,D'Incà R,et al. Diagnosis and management of Wilson’s disease:results of a single centerexperience. J Clin Gastroenterol,2006,40（10）:936-941.
[11] Rosencrantz R,Schilsky M. Wilson disease:pathogenesis and clinical considerations in diagnosis and treatment. Semin Liver Dis,2011,31（3）:245-259.
[12] Stromeyer FW,Ishak KG. Histology of the liver in Wilson’s disease:a studyof 34 cases. Am J Clin Pathol,1980,73（1）:12-24.
[13] Ferenci P,Caca K,Loudianos G,et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int,2003,23（3）:139-142.
[14] Seo JK. Diagnosis of Wilson disease in young children:Molecular genetic testing and a paradigm shift from the laboratory diagnosis. Pediatr Gastroenterol Hepatol Nutr,2012,15（4）:197-209.
[15] Korman JD,Volenberg I,Balko J,et al. Screening for Wilson’sdisease in acute liver failure:a comparison of currentlyavailable diagnostic tests. Hepatology,2008,48（4）:1167-1174.
[16] Ferenci P. Review article: diagnosis and current therapy of Wilson’s disease. Aliment Pharmacol Ther,2004,19（2）:157-165.
[17] Frommer D, Morris J,Sherlock S,et al. Kayser-Fleischer rings in patients without Wilson’s disease. Gastroenterology,1977,72（6）:1331-1335.
[18] Harada M. Wilson disease and its current problems. Intern Med,2010,49（9）:807-808.
[19] 李光明,范建高. 肝豆状核变性的诊断与治疗进展. 实用肝脏病杂志,2012,15（6）:493-495.
[20] Merle U, Schaefer M,Ferenci P,et al. Clinicalpresentation, diagnosis andlong-term outcome of Wilson’sdisease:a cohort study. Gut,2007,56（1）:115-120.
[21] 杨旭. 更新观念, 提高我国肝豆状核变性诊治的临床水平. 临床肝胆病杂志,2013,29（12）:905-908.
[22] Askari FK,Greenson J,Dick RD,et al. Treatment of Wilson’s disease with zinc. XVIII. Initialtreatment of the hepatic decompensation presentation withtrientine and zinc. J Lab Clin Med,2003,142（6）:385-390.
[23] Ranucci G,Di Dato F,Spagnuolo MI,et al. Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood:a retrospective study. Orphanet J Rare Dis,2014,9（1）:41.
[24] Brewer GJ, Dick RD,Johnson VD,et al. Treatment of Wilson’s disease with zinc XVI:treatment during the pediatric years. J Lab Clin Med,2001,137（3）:191-198.
[25] Alam ST,Rahman MM,Islam KA,et al. Neurologic manifestations,diagnosis and management of Wilson's disease in children-an update. Mymensingh Med J,2014,23（1）:195-203.
[26] Dong QY,Wu ZY. Advance in the pathogenesis and treatment of Wilson disease.Transl Neurodegener,2012,1（1）:23.
[27] Zegarac Z,Duic Z,Stasenko S,et al. Wilson's disease in pregnancy. Acta Clin Croat,2013,52（4）:529-532.
[28] Buamah P,Russell M,Milford-Ward A,et al. Serum copper concentration significantly less in abnormal pregnancies. Clinical chemistry,1984,30（10）:1676-1677.
[29] Schilsky ML.Diagnosis and long-term management of Wilson disease. Gastroenterol Hepatol,2007,3（1）:27-29.
[30] Jhang JS,Schilsky ML,Lefkowitch JH,et al. Therapeutic plasmapheresis as a bridge to liver transplantationin fulminant Wilson disease. J Clin Apher,2007,22（1）:10-14.
[31] Schilsky ML. Liver transplantation for Wilson's disease.Ann N Y Acad Sci,2014,1315（1）:45-49.
[32] Arnon R,Annunziato R,Schilsky M,et al. Liver transplantation for children withWilson disease:comparison of outcomes between children and adults. Clin Transplant,2011,25（1）:E52-E60.
[33] Hermann W,Eggers B,Wagner A. The indication for liver transplantto improve neurological symptoms in a patient with Wilson'sdisease. J Neurol,2002,249（12）:1733-1734.
[34] Geissler I,Heinemann K,Rohm S,et al. Liver transplantationfor hepatic and neurological Wilson's disease. Transplant P,2003,35（4）:1445-1446.
[35] Dhawan A,Taylor RM,Cheeseman P,et al. Wilson’s disease in children:37-year experience and revised King’s score for liver transplantation. Liver Transpl,2005,11（4）:441-448.

特殊人群肝豆状核变性诊治进展^*

What is special in patients with Wilson's disease in children and pregnant women

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	鲍应军, 任伟新. 门静脉血栓介入治疗研究进展[J]. 实用肝脏病杂志, 2019, 22(6): 768-769.
[2]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[3]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[4]	石莹莹, 王元喜. 替比夫定联合阿德福韦酯治疗慢性乙型肝炎患者效果及其对肾功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 820-823.
[5]	吴海义, 陈建新. 四种诊断模型诊断乙型肝炎病毒携带者肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 832-835.
[6]	邢欣, 魏重操, 周咪咪, 李小玲, 邓江, 鲁晓岚. 牛磺熊去氧胆酸与熊去氧胆酸治疗非酒精性脂肪性肝病患者疗效和安全性的Meta分析[J]. 实用肝脏病杂志, 2019, 22(6): 852-855.
[7]	段楚瑶, 陈庆山, 汪黎明, 贺晓琪. 熊去氧胆酸治疗妊娠期肝内胆汁淤积症患者疗效研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 864-867.
[8]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[9]	马雅琼, 李芝兰, 夏冰. 早期肠内营养联合微生态制剂治疗肝性脑病患者肠道菌群的改变^*[J]. 实用肝脏病杂志, 2019, 22(6): 892-895.
[10]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[11]	曾艳妮, 张灿, 毕俊英, 刘良进, 孟俊, 秦涛. MRI长时间延迟增强扫描诊断肝脏孤立性坏死性结节价值研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 900-903.
[12]	冯文广, 姜伟, 宋国军. PPV指导术中液体治疗对行肝部分切除术治疗的肝内胆管结石患者术后并发症发生的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 912-915.
[13]	黎秋曦, 贾健锋, 黄锐. 区段肝蒂肝切除术与B超引导下肝切除术治疗肝胆管结石患者临床价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 916-919.
[14]	李传杰, 徐静, 王亮亮, 潘劲劲, 刘波. 恩替卡韦治疗慢性乙型肝炎患者血清HBsAg变化与病毒学应答的相关性研究[J]. 实用肝脏病杂志, 2019, 22(6): 928-929.
[15]	张瑞, 王剑, 陈世耀. 肝硬化门脉高压症并发血栓形成机制和治疗研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 930-933.